{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:54Z","timestamp":1786116354079,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00059-025-05348-4","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:27:25Z","timestamp":1762558045000},"page":"300-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Procedural hospital volume and outcome after transcatheter edge-to-edge mitral valve repair","Volumen der Prozeduren im Krankenhaus und Ergebnisse nach Transkatheter-Edge-to-Edge-Mitralklappenrekonstruktion"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1078-6807","authenticated-orcid":false,"given":"Julinda","family":"Mehilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Bestehorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Perings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Sch\u00e4chinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffi","family":"Bekeredjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Zauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Bestehorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,8]]},"reference":[{"issue":"14","key":"5348_CR1","doi-asserted-by":"publisher","first-page":"e1126","DOI":"10.4244\/EIJ-E-21-00009","volume":"17","author":"A Vahanian","year":"2022","unstructured":"Vahanian\u00a0A, Beyersdorf\u00a0F, Praz\u00a0F et al (2022) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. EuroIntervention 17(14):e1126\u2013e1196","journal-title":"EuroIntervention"},{"issue":"12","key":"5348_CR2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4244\/EIJ-D-22-00725","volume":"18","author":"J Hausleiter","year":"2023","unstructured":"Hausleiter\u00a0J, Stocker\u00a0TJ, Adamo\u00a0M et al (2023) Mitral valve transcatheter edge-to-edge repair. EuroIntervention 18(12):957\u2013976","journal-title":"EuroIntervention"},{"issue":"24","key":"5348_CR3","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1016\/j.jacc.2019.09.014","volume":"74","author":"AK Chhatriwalla","year":"2019","unstructured":"Chhatriwalla\u00a0AK, Vemulapalli\u00a0S, Szerlip\u00a0M et al (2019) Operator experience and outcomes of Transcatheter mitral valve repair in the United States. J\u00a0Am Coll Cardiol 74(24):2955\u20132965","journal-title":"J Am Coll Cardiol"},{"key":"5348_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.carrev.2021.09.007","volume":"39","author":"SN Dodoo","year":"2022","unstructured":"Dodoo\u00a0SN, Okoh\u00a0AK, Oseni\u00a0A et al (2022) Adverse events following Transcatheter edge-to-edge repair (TEER) using Mitraclip: lessons learned from the manufacturer and user facility device experience (MAUDE) registry. Cardiovasc Revasc Med 39:101\u2013105","journal-title":"Cardiovasc Revasc Med"},{"issue":"3","key":"5348_CR5","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jtcvs.2014.08.084","volume":"149","author":"CM Vassileva","year":"2015","unstructured":"Vassileva\u00a0CM, McNeely\u00a0C, Spertus\u00a0J et al (2015) Hospital volume, mitral repair rates, and mortality in mitral valve surgery in the elderly: an analysis of US hospitals treating medicare fee-for-service patients. J\u00a0Thorac Cardiovasc Surg 149(3):762\u2013768 e761","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"5348_CR6","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/jocs.15310","volume":"36","author":"SL Wayne","year":"2021","unstructured":"Wayne\u00a0SL, Martin\u00a0C, Smith\u00a0JA, Almeida\u00a0AA (2021) Mitral valve repair rates in degenerative mitral valve disease correlate with surgeon and hospital procedural volume. J\u00a0Card Surg 36(4):1419\u20131426","journal-title":"J Card Surg"},{"key":"5348_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12181-021-00521-5","volume":"16","author":"BS BRv","year":"2022","unstructured":"Baldus\u00a0S, von Bardeleben\u00a0RS, Eggebrecht\u00a0H et\u00a0al (2022) Addendum zum Positionspapier der Deutschen Gesellschaft f\u00fcr Kardiologie \u201eInterventionelle Therapie von AV-Klappenerkrankungen \u2013 Kriterien f\u00fcr die Zertifizierung von Mitralklappenzentren\u201c. Kardiologe 16:140-141","journal-title":"Kardiologe"},{"issue":"6","key":"5348_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00059-023-05212-3","volume":"48","author":"M Puls","year":"2023","unstructured":"Puls\u00a0M (2023) Mitral valve transcatheter edge-to-edge repair (M-TEER) in Germany : treatment reality, potential needs, possible quality indicators and open questions. Herz 48(6):437\u2013447","journal-title":"Herz"},{"issue":"28","key":"5348_CR9","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/eurheartj\/ehw190","volume":"37","author":"H Eggebrecht","year":"2016","unstructured":"Eggebrecht\u00a0H, Bestehorn\u00a0M, Haude\u00a0M et al (2016) Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart\u00a0J 37(28):2240\u20132248","journal-title":"Eur Heart J"},{"issue":"29","key":"5348_CR10","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/eurheartj\/ehv333","volume":"36","author":"GW Stone","year":"2015","unstructured":"Stone\u00a0GW, Adams\u00a0DH, Abraham\u00a0WT et al (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a\u00a0consensus document from the mitral valve academic research consortium. Eur Heart\u00a0J 36(29):1878\u20131891","journal-title":"Eur Heart J"},{"key":"5348_CR11","unstructured":"Bundesqualit\u00e4tsbericht (2022ed) Data from: QS-Verfahren Koronarchirurgie und Eingriffe an Herzklappen. Erfassungsjahre 2020 und 2021. 15.08.2022, updated version\u00a028. https:\/\/doi.org\/10.2022ed. Berlin: IQTIG \u2013 Institut f\u00fcr Qualit\u00e4tssicherung und Transparenz im Gesundheitswesen. https:\/\/iqtig.org\/downloads\/berichte\/2022\/IQTIG_Bundesqualitaetsbericht-2022_2022-10-28.pdf"},{"issue":"10","key":"5348_CR12","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/eurheartj\/ehac698","volume":"44","author":"K Bestehorn","year":"2023","unstructured":"Bestehorn\u00a0K, Bestehorn\u00a0M, Zahn\u00a0R et al (2023) Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany. Eur Heart\u00a0J 44(10):856\u2013867","journal-title":"Eur Heart J"},{"issue":"24","key":"5348_CR13","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"GW Stone","year":"2018","unstructured":"Stone\u00a0GW, Lindenfeld\u00a0J, Abraham\u00a0WT et al (2018) Transcatheter mitral-valve repair in patients with heart failure. N\u00a0Engl J Med 379(24):2307\u20132318","journal-title":"N Engl J Med"},{"issue":"24","key":"5348_CR14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"JF Obadia","year":"2018","unstructured":"Obadia\u00a0JF, Messika-Zeitoun\u00a0D, Leurent\u00a0G et al (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N\u00a0Engl J Med 379(24):2297\u20132306","journal-title":"N Engl J Med"},{"issue":"11","key":"5348_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s00392-014-0734-y","volume":"103","author":"J Ledwoch","year":"2014","unstructured":"Ledwoch\u00a0J, Franke\u00a0J, Baldus\u00a0S et al (2014) Impact of the learning curve on outcome after transcatheter mitral valve repair: results from the German mitral valve registry. Clin Res Cardiol 103(11):930\u2013937","journal-title":"Clin Res Cardiol"},{"key":"5348_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.carrev.2021.04.017","volume":"36","author":"D Kolte","year":"2022","unstructured":"Kolte\u00a0D, Butala\u00a0NM, Kennedy\u00a0KF et al (2022) Association between hospital cardiovascular procedural volumes and Transcatheter mitral valve repair outcomes. Cardiovasc Revasc Med 36:27\u201333","journal-title":"Cardiovasc Revasc Med"},{"issue":"20","key":"5348_CR17","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1016\/j.jcin.2020.06.053","volume":"13","author":"T Chakravarty","year":"2020","unstructured":"Chakravarty\u00a0T, Makar\u00a0M, Patel\u00a0D et al (2020) Transcatheter edge-to-edge mitral valve repair with the Mitraclip G4 system. JACC Cardiovasc Interv 13(20):2402\u20132414","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"5348_CR18","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1016\/j.jacc.2021.10.011","volume":"78","author":"B Koell","year":"2021","unstructured":"Koell\u00a0B, Orban\u00a0M, Weimann\u00a0J et al (2021) Outcomes stratified by adapted inclusion criteria after mitral edge-to-edge repair. J\u00a0Am Coll Cardiol 78(24):2408\u20132421","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"5348_CR19","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.jcin.2019.02.039","volume":"12","author":"AK Chhatriwalla","year":"2019","unstructured":"Chhatriwalla\u00a0AK, Vemulapalli\u00a0S, Holmes\u00a0DR Jr. et al (2019) Institutional experience with Transcatheter mitral valve repair and clinical outcomes: insights from the TVT registry. JACC Cardiovasc Interv 12(14):1342\u20131352","journal-title":"JACC Cardiovasc Interv"},{"key":"5348_CR20","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4244\/EIJ-D-17-00062","volume":"13","author":"K Bestehorn","year":"2017","unstructured":"Bestehorn\u00a0K, Eggebrecht\u00a0H, Fleck\u00a0E et al (2017) Volume-outcome1relationship with transfemoral transcatheter aortic valve implantation (TAVI): insights from the compulsory German quality assurance registry on aortic valve replacement (AQUA). EuroIntervention 13:914\u2013920","journal-title":"EuroIntervention"},{"issue":"10","key":"5348_CR21","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/eurheartj\/ehac698","volume":"44","author":"K Bestehorn","year":"2023","unstructured":"Bestehorn\u00a0K, Bestehorn\u00a0M, Zahn\u00a0R et al (2023) Transfemoral aortic valve implantation: procedural hospital volume and mortality in Germany. Eur Heart\u00a0J 44(10):856\u2013867. https:\/\/doi.org\/10.1093\/eurheartj\/ehac698","journal-title":"Eur Heart J"},{"issue":"3","key":"5348_CR22","doi-asserted-by":"publisher","first-page":"e003186","DOI":"10.1161\/CIRCOUTCOMES.116.003186","volume":"10","author":"D O\u2019Neill","year":"2017","unstructured":"O\u2019Neill\u00a0D, Nicholas\u00a0O, Gale\u00a0CP et al (2017) Total center Percutaneous coronary intervention volume and 30-day mortality: a\u00a0contemporary national cohort study of 427 467 elective, urgent, and emergency cases. Circ Cardiovasc Qual Outcomes 10(3):e3186. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.116.003186","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"5348_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12688\/hrbopenres.13203.1","volume":"4","author":"KA Walsh","year":"2021","unstructured":"Walsh\u00a0KA, Plunkett\u00a0T, O\u2019Brien\u00a0KK et al (2021) The relationship between procedural volume and patient outcomes for percutaneous coronary interventions: a\u00a0systematic review and meta-analysis. HRB Open Res 4:10. https:\/\/doi.org\/10.12688\/hrbopenres.13203.1","journal-title":"HRB Open Res"},{"key":"5348_CR24","volume-title":"Relationship between volume of services and quality of treatment outcome for transcatheter aortic valve implantation (TAVI): IQWiG reports\u2014commission no. V20-04","author":"-","year":"2021","unstructured":"- (2021) Relationship between volume of services and quality of treatment outcome for transcatheter aortic valve implantation (TAVI): IQWiG reports\u2014commission no. V20-04. Cologne (Germany)"},{"issue":"10","key":"5348_CR25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1200\/JCO.21.01488","volume":"40","author":"P Baum","year":"2022","unstructured":"Baum\u00a0P, Lenzi\u00a0J, Diers\u00a0J et al (2022) Risk-adjusted mortality rates as a\u00a0quality proxy outperform volume in surgical oncology\u2011A new perspective on hospital centralization using national population-based data. J\u00a0Clin Oncol 40(10):1041\u20131050","journal-title":"J Clin Oncol"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05348-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T09:17:55Z","timestamp":1786007875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05348-4"}},"subtitle":["Analysis of the German mandatory quality registry","Analyse des deutschen verpflichtenden Qualit\u00e4tsregisters"],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5348"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05348-4","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,8]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Mehilli has received lecture fees from AstraZeneca, Daiichi Sankyo, Boston Scientific, Biotronik, and SchockWave. K.\u00a0Bestehorn has stock or stock options for Merck & Co., Fresenius, and Astra Zeneca. R.\u00a0Zahn has received lecture fees for Edwards Lifescience, Medtronic, and Abbott. M.\u00a0Bestehorn, C.\u00a0Perings, V.\u00a0Sch\u00e4chinger, H.\u00a0Schmidt, C.\u00a0Stellbrink, I.\u00a0Ott, R.\u00a0Bekeredjian and F.\u00a0Zauner declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}